5325042022-04-012022-06-305325042022-04-012022-06-30in-bse-fin:OtherExpenses1Member5325042022-04-012022-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares532504NAVINFLUORINE048G01026Navin Fluorine International LimitedEquity2022-04-012023-03-312022-07-232022-06-29INRCroresFirst quarterSingle segmentChemicals2022-07-2313:30:002022-07-2315:45:00Not applicable2022-04-012022-06-30UnauditedStandalone3868300000142400000401070000018563000000-9770000043970000032000001149000006710000002987400000102330000001023300000242100000-8500000233600000078970000000007897000000789700000789700000099100000215.9415.930015.9415.931. The results of the quarter ended 30th June, 2022 were reviewed by the Audit Committee and approved <BR> by the Board of Directors of the Company, at its meeting held on 23rd July, 2022. They have been <BR> subjected to limited review by the statutory auditors. <BR> <BR> 2. The figures for the quarter ended 31 st March, 2022 are balancing figures between the audited figures in <BR> respect of the full financial year and the published year to date figures for the nine months period ended <BR> 31 st December, 2021 . <BR> <BR> 3. Other Income for the quarter ended 30 th June, 2022 includes interest of Rs.0.91 crores received on refund <BR> of income tax. (Quarter and year ended 31 st March, 2022 includes interest of Rs.5.30 crores). <BR> <BR> 4. The Company has identified Chemicals business as its only primary reportable segment in accordance <BR> with the requirements of Ind AS 108, 'Operating Segments'. Accordingly, no separate segment <BR> information has been provided. <BR> <BR> 5. Previous period·s figures have been regrouped, wherever necessary, to correspond to those of the current <BR> period. <BR> <BR> Other Expenses671000000Remeasurement loss of the defined benefit obligation0000